Trial intelligence / Profile preview

Effect of liraglutide on intragastric pressure and satiation during nutrient drink infusion

2010-023226-20Phase 4Completed

Sponsor
KU Leuven
Start
Dec 2010
Modality
Peptides
Countries
1
01

Overview

Phase 4, single-arm trial of liraglutide, sponsored by KU Leuven. Primary endpoint: Liquid nutrient tolerance to reach maximum satiation. Started Dec 2010; status: completed.

02

Drugs

Beyond the preview

Go deeper on 2010-023226-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-023226-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call